Cargando…
Bioinspired Lipid Nanocarriers for RNA Delivery
[Image: see text] RNA therapy is a disruptive technology comprising a rapidly expanding category of drugs. Further translation of RNA therapies to the clinic will improve the treatment of many diseases and help enable personalized medicine. However, in vivo delivery of RNA remains challenging due to...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10125326/ https://www.ncbi.nlm.nih.gov/pubmed/37101812 http://dx.doi.org/10.1021/acsbiomedchemau.2c00073 |
_version_ | 1785030003564478464 |
---|---|
author | Golubovic, Alex Tsai, Shannon Li, Bowen |
author_facet | Golubovic, Alex Tsai, Shannon Li, Bowen |
author_sort | Golubovic, Alex |
collection | PubMed |
description | [Image: see text] RNA therapy is a disruptive technology comprising a rapidly expanding category of drugs. Further translation of RNA therapies to the clinic will improve the treatment of many diseases and help enable personalized medicine. However, in vivo delivery of RNA remains challenging due to the lack of appropriate delivery tools. Current state-of-the-art carriers such as ionizable lipid nanoparticles still face significant challenges, including frequent localization to clearance-associated organs and limited (1–2%) endosomal escape. Thus, delivery vehicles must be improved to further unlock the full potential of RNA therapeutics. An emerging strategy is to modify existing or new lipid nanocarriers by incorporating bioinspired design principles. This method generally aims to improve tissue targeting, cellular uptake, and endosomal escape, addressing some of the critical issues facing the field. In this review, we introduce the different strategies for creating bioinspired lipid-based RNA carriers and discuss the potential implications of each strategy based on reported findings. These strategies include incorporating naturally derived lipids into existing nanocarriers and mimicking bioderived molecules, viruses, and exosomes. We evaluate each strategy based on the critical factors required for delivery vehicles to succeed. Finally, we point to areas of research that should be furthered to enable the more successful rational design of lipid nanocarriers for RNA delivery. |
format | Online Article Text |
id | pubmed-10125326 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | American Chemical Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-101253262023-04-25 Bioinspired Lipid Nanocarriers for RNA Delivery Golubovic, Alex Tsai, Shannon Li, Bowen ACS Bio Med Chem Au [Image: see text] RNA therapy is a disruptive technology comprising a rapidly expanding category of drugs. Further translation of RNA therapies to the clinic will improve the treatment of many diseases and help enable personalized medicine. However, in vivo delivery of RNA remains challenging due to the lack of appropriate delivery tools. Current state-of-the-art carriers such as ionizable lipid nanoparticles still face significant challenges, including frequent localization to clearance-associated organs and limited (1–2%) endosomal escape. Thus, delivery vehicles must be improved to further unlock the full potential of RNA therapeutics. An emerging strategy is to modify existing or new lipid nanocarriers by incorporating bioinspired design principles. This method generally aims to improve tissue targeting, cellular uptake, and endosomal escape, addressing some of the critical issues facing the field. In this review, we introduce the different strategies for creating bioinspired lipid-based RNA carriers and discuss the potential implications of each strategy based on reported findings. These strategies include incorporating naturally derived lipids into existing nanocarriers and mimicking bioderived molecules, viruses, and exosomes. We evaluate each strategy based on the critical factors required for delivery vehicles to succeed. Finally, we point to areas of research that should be furthered to enable the more successful rational design of lipid nanocarriers for RNA delivery. American Chemical Society 2023-01-16 /pmc/articles/PMC10125326/ /pubmed/37101812 http://dx.doi.org/10.1021/acsbiomedchemau.2c00073 Text en © 2023 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by-nc-nd/4.0/Permits non-commercial access and re-use, provided that author attribution and integrity are maintained; but does not permit creation of adaptations or other derivative works (https://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Golubovic, Alex Tsai, Shannon Li, Bowen Bioinspired Lipid Nanocarriers for RNA Delivery |
title | Bioinspired Lipid Nanocarriers for RNA Delivery |
title_full | Bioinspired Lipid Nanocarriers for RNA Delivery |
title_fullStr | Bioinspired Lipid Nanocarriers for RNA Delivery |
title_full_unstemmed | Bioinspired Lipid Nanocarriers for RNA Delivery |
title_short | Bioinspired Lipid Nanocarriers for RNA Delivery |
title_sort | bioinspired lipid nanocarriers for rna delivery |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10125326/ https://www.ncbi.nlm.nih.gov/pubmed/37101812 http://dx.doi.org/10.1021/acsbiomedchemau.2c00073 |
work_keys_str_mv | AT golubovicalex bioinspiredlipidnanocarriersforrnadelivery AT tsaishannon bioinspiredlipidnanocarriersforrnadelivery AT libowen bioinspiredlipidnanocarriersforrnadelivery |